Nexavar (sorafenib tablets) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has relapsed or advanced disease
• Patient has clear cell histology
• Patient has tried at least one systemic therapy (e.g., Inlyta [axitinib tablets], pazopanib, sunitinib, Cabometyx [cabozantinib tablets])

Approval duration

1 year